Diplomat Pharmacy, Inc. (DPLO) Reaches $5.55 52-Week Low; Mohawk Industries (MHK) Shorts Decreased By 6.97%

Diplomat Pharmacy, Inc. (NYSE:DPLO) Logo

Mohawk Industries Inc (NYSE:MHK) had a decrease of 6.97% in short interest. MHK’s SI was 4.01 million shares in March as released by FINRA. Its down 6.97% from 4.31M shares previously. With 1.58 million avg volume, 3 days are for Mohawk Industries Inc (NYSE:MHK)’s short sellers to cover MHK’s short positions. The SI to Mohawk Industries Inc’s float is 6.55%. The stock decreased 0.53% or $0.69 during the last trading session, reaching $128.57. About 970,482 shares traded. Mohawk Industries, Inc. (NYSE:MHK) has declined 42.67% since March 17, 2018 and is downtrending. It has underperformed by 47.04% the S&P500. Some Historical MHK News: 21/04/2018 – DJ Mohawk Industries Inc, Inst Holders, 1Q 2018 (MHK); 26/04/2018 – MOHAWK INDUSTRIES INC – QTRLY ADJ SHR $3.01; 29/03/2018 – Decommissioned Downtown Alectra Utilities’ Substation Becomes Mohawk’s New Energy and Power Utilities Lab; 13/03/2018 NY Warn Notices: 3 / 13 / 2018 – Conduent Education Services, LLC – Mohawk Valley Region; 01/05/2018 – Mohawk Industries at Non-Deal Roadshow Hosted By SunTrust Today; 26/04/2018 – MOHAWK INDUSTRIES 1Q ADJ EPS $3.01, EST. $3; 01/05/2018 – Invesque Inc. Closes on Previously Announced Acquisition of Toronto Based Mohawk Medical Properties REIT; 26/04/2018 – Correct: Mohawk Sees 2Q Adj EPS $3.89-Adj EPS $3.98, Not EPS; 01/05/2018 – JPMorgan Large Cap Value Adds Mohawk Industries; 09/04/2018 – Virginia Gov: Governor Northam Announces Mohawk Industries to Expand in Carroll County

The stock of Diplomat Pharmacy, Inc. (NYSE:DPLO) hit a new 52-week low and has $5.16 target or 7.00% below today’s $5.55 share price. The 6 months bearish chart indicates high risk for the $413.05 million company. The 1-year low was reported on Mar, 17 by Barchart.com. If the $5.16 price target is reached, the company will be worth $28.91 million less. The stock decreased 13.55% or $0.87 during the last trading session, reaching $5.55. About 4.32 million shares traded or 222.26% up from the average. Diplomat Pharmacy, Inc. (NYSE:DPLO) has declined 69.53% since March 17, 2018 and is downtrending. It has underperformed by 73.90% the S&P500. Some Historical DPLO News: 30/04/2018 – Diplomat Launches CastiaRx, Industry-Leading Specialty Benefit Manager; 07/05/2018 – Diplomat Pharmacy Raises 2018 View To Rev $5.5B-$5.9B; 07/05/2018 – Diplomat Pharmacy 1Q Loss/Shr 1c; 10/05/2018 – DIPLOMAT PHARMACY NAMES BRIAN GRIFFIN AS CEO & CHAIRMAN OF; 08/05/2018 – DIPLOMAT PHARMACY EXPECTS TO NAME NEXT CEO BY END OF THIS WEEK; 10/05/2018 – Diplomat Pharmacy Appoints Brian Griffin As Chief Executive Officer And Chairman Of The Board; 07/05/2018 – DIPLOMAT PHARMACY INC SEES FY 2018 REVENUE BETWEEN $5.5 BLN AND $5.9 BLN; 07/05/2018 – Diplomat Pharmacy 1Q Adj EPS 20c; 08/05/2018 – Diplomat Pharmacy’s Jeff Park Resigns Voluntarily as Interim CEO; 08/05/2018 – Diplomat Pharmacy Financial Chief Atul Kavthekar to Temporarily Assume Added CEO Responsibilities

Investors sentiment decreased to 0.86 in 2018 Q4. Its down 0.11, from 0.97 in 2018Q3. It worsened, as 90 investors sold Mohawk Industries, Inc. shares while 132 reduced holdings. 71 funds opened positions while 121 raised stakes. 55.11 million shares or 2.36% more from 53.84 million shares in 2018Q3 were reported. Stephens Ar stated it has 0.05% in Mohawk Industries, Inc. (NYSE:MHK). Nelson Van Denburg & Campbell Wealth Group Ltd Limited Liability Company has invested 0.02% in Mohawk Industries, Inc. (NYSE:MHK). Amica Pension Fund Board Of Trustees holds 5,422 shares. New York-based Cibc World Mkts Corp has invested 0.01% in Mohawk Industries, Inc. (NYSE:MHK). Eagle Capital Mngmt Ltd Liability reported 2.12% stake. Nottingham has 2,853 shares for 0.09% of their portfolio. D E Shaw reported 1.01M shares stake. Madison Invest Holdings stated it has 0.53% in Mohawk Industries, Inc. (NYSE:MHK). Financial Bank Of Montreal Can stated it has 0% in Mohawk Industries, Inc. (NYSE:MHK). Chilton Invest owns 4,612 shares. Wealthtrust holds 0% or 50 shares in its portfolio. 75,300 are owned by Lord Abbett Co Limited. 283,407 were accumulated by Royal Natl Bank Of Canada. Amica Retiree Medical Trust holds 0.09% of its portfolio in Mohawk Industries, Inc. (NYSE:MHK) for 848 shares. George Kaiser Family Foundation invested in 0.33% or 8,376 shares.

Mohawk Industries, Inc. designs, manufactures, sources, distributes, and markets flooring products for remodeling and new constructions of residential and commercial spaces worldwide. The company has market cap of $9.30 billion. It operates through three divisions: Global Ceramic, Flooring North America , and Flooring Rest of the World (Flooring ROW). It has a 2.58 P/E ratio. The Global Ceramic segment provides a range of ceramic tile, porcelain tile, and natural stone products; and sources, markets, and distributes other tile related products.

Since October 29, 2018, it had 11 insider buys, and 3 selling transactions for $55.71 million activity. $29.60M worth of Mohawk Industries, Inc. (NYSE:MHK) shares were bought by BALCAEN FILIP. Carson Brian also bought $313,877 worth of Mohawk Industries, Inc. (NYSE:MHK) on Monday, October 29. The insider Patton Rodney David sold 763 shares worth $95,583. 1,000 shares were bought by BRUCKMANN BRUCE, worth $117,750. HELEN SUZANNE L sold $2.00M worth of Mohawk Industries, Inc. (NYSE:MHK) on Monday, February 11.

Among 10 analysts covering Mohawk Industries (NYSE:MHK), 4 have Buy rating, 4 Sell and 2 Hold. Therefore 40% are positive. Mohawk Industries had 13 analyst reports since October 9, 2018 according to SRatingsIntel. The firm earned “Sector Perform” rating on Monday, October 15 by RBC Capital Markets. As per Monday, October 29, the company rating was maintained by Wells Fargo. Barclays Capital maintained it with “Overweight” rating and $140 target in Monday, October 29 report. Nomura maintained Mohawk Industries, Inc. (NYSE:MHK) rating on Friday, October 26. Nomura has “Buy” rating and $185 target. On Monday, October 29 the stock rating was maintained by Raymond James with “Outperform”. The firm earned “Neutral” rating on Monday, October 29 by Credit Suisse. The rating was maintained by Wells Fargo with “Market Perform” on Monday, February 11. The firm earned “Outperform” rating on Wednesday, October 10 by Raymond James. The stock of Mohawk Industries, Inc. (NYSE:MHK) earned “Underperform” rating by RBC Capital Markets on Friday, January 11. The rating was maintained by SunTrust on Monday, October 29 with “Buy”.

More important recent Mohawk Industries, Inc. (NYSE:MHK) news were published by: Seekingalpha.com which released: “Mohawk Industries: Weak In 2019 – Seeking Alpha” on March 12, 2019, also Gurufocus.com published article titled: “John Rogers Adds to Philip Morris, Stericycle – GuruFocus.com”, Gurufocus.com published: “Dr. Michael Burry of ‘Big Short’ Reveals Stakes in Google, Facebook – GuruFocus.com” on February 21, 2019. More interesting news about Mohawk Industries, Inc. (NYSE:MHK) was released by: Seekingalpha.com and their article: “Mohawk Q4 2018 Earnings Preview – Seeking Alpha” with publication date: February 06, 2019.

Investors sentiment increased to 1.06 in 2018 Q4. Its up 0.05, from 1.01 in 2018Q3. It is positive, as 26 investors sold Diplomat Pharmacy, Inc. shares while 42 reduced holdings. 19 funds opened positions while 53 raised stakes. 63.85 million shares or 3.37% more from 61.77 million shares in 2018Q3 were reported. The United Kingdom-based Legal General Grp Public Lc has invested 0% in Diplomat Pharmacy, Inc. (NYSE:DPLO). Cubist Systematic Strategies Lc invested in 11,468 shares. Capital World Investors holds 6.00 million shares or 0.02% of its portfolio. Royal Bank & Trust Of Canada accumulated 3,393 shares or 0% of the stock. Jpmorgan Chase Co accumulated 74,085 shares or 0% of the stock. State Of Alaska Department Of Revenue reported 0% in Diplomat Pharmacy, Inc. (NYSE:DPLO). Fcg Advsrs Ltd Liability has invested 0.17% in Diplomat Pharmacy, Inc. (NYSE:DPLO). Blair William & Il has invested 0.01% in Diplomat Pharmacy, Inc. (NYSE:DPLO). Utd Automobile Association reported 11,522 shares. Arizona State Retirement System accumulated 0.02% or 87,165 shares. Moreover, Capital Intll Invsts has 0.04% invested in Diplomat Pharmacy, Inc. (NYSE:DPLO) for 6.03 million shares. The New York-based Blackrock Inc has invested 0.01% in Diplomat Pharmacy, Inc. (NYSE:DPLO). Numerixs Inv Inc holds 0% or 900 shares. Art Advisors Limited Co holds 0.05% or 60,321 shares. State Of Tennessee Treasury Department has 0% invested in Diplomat Pharmacy, Inc. (NYSE:DPLO) for 33,997 shares.

Among 5 analysts covering Diplomat Pharmacy (NYSE:DPLO), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Diplomat Pharmacy has $18 highest and $8 lowest target. $13’s average target is 134.23% above currents $5.55 stock price. Diplomat Pharmacy had 11 analyst reports since November 7, 2018 according to SRatingsIntel. Morgan Stanley maintained Diplomat Pharmacy, Inc. (NYSE:DPLO) rating on Monday, December 3. Morgan Stanley has “Equal-Weight” rating and $18 target. Wells Fargo maintained Diplomat Pharmacy, Inc. (NYSE:DPLO) on Thursday, November 8 with “Market Perform” rating. Mizuho maintained the shares of DPLO in report on Friday, February 22 with “Hold” rating. The firm earned “Underperform” rating on Wednesday, November 7 by Robert W. Baird. The company was maintained on Monday, February 25 by Barclays Capital. The firm earned “Neutral” rating on Friday, December 7 by Robert W. Baird.

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company has market cap of $413.05 million. The firm stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It currently has negative earnings. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems.

Diplomat Pharmacy, Inc. (NYSE:DPLO) Institutional Positions Chart